Core Laboratories N.V. (NYSE: CLB) is -5.92% lower on its value in year-to-date trading and has touched a low of $13.19 and a high of $35.83 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CLB stock was last observed hovering at around $21.12 in the last trading session, with the day’s loss setting it -0.13% off its average median price target of $20.00 for the next 12 months. It is also 34.41% off the consensus price target high of $32.00 offered by 11 analysts, but current levels are -61.46% lower than the price target low of $13.00 for the same period.
Currently trading at $20.99, the stock is 0.50% and 15.82% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.24 million and changing -0.62% at the moment leaves the stock -6.92% off its SMA200. CLB registered -18.67% loss for a year compared to 6-month loss of -19.73%.
The stock witnessed a 4.95% gain in the last 1 month and extending the period to 3 months gives it a 18.59%, and is -5.87% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.57% over the week and 5.37% over the month.
Core Laboratories N.V. (CLB) has around 3700 employees, a market worth around $1.01B and $487.30M in sales. Current P/E ratio is 64.19 and Fwd P/E is 21.44. Profit margin for the company is 3.20%. Distance from 52-week low is 59.14% and -41.42% from its 52-week high. The company has generated returns on investments over the last 12 months (8.50%).
Core Laboratories N.V. (CLB) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Core Laboratories N.V. (CLB) is a “Hold”. 11 analysts offering their recommendations for the stock have an average rating of 3.00, where 5 rate it as a Hold and 2 think it is a “Overweight”. 1 of the analysts rate the stock as a “Buy”. 2 analysts have rated the stock as a Sell or Underperform.
Core Laboratories N.V. is expected to release its quarterly report on 02/01/2023.The EPS is expected to grow by 119.30% this year
Core Laboratories N.V. (CLB) Top Institutional Holders
The shares outstanding are 46.34M, and float is at 46.13M with Short Float at 8.77%.
Core Laboratories N.V. (CLB) Insider Activity
A total of 8 insider transactions have happened at Core Laboratories N.V. (CLB) in the last six months, with sales accounting for 4 and purchases happening 4 times.
Core Laboratories N.V. (CLB): Who are the competitors?
The company’s main competitors (and peers) include Schlumberger Limited (SLB) that is trading 64.91% up over the past 12 months and Helix Energy Solutions Group Inc. (HLX) that is 80.75% higher over the same period.